Aytu Biopharma (AYTU) Other financing activities (2015 - 2026)

Aytu Biopharma (AYTU) has 12 years of Other financing activities data on file, last reported at $148000.0 in Q1 2026.

• Other financing activities for Q1 2026 came in at $148000.0, up 6.47% year-over-year; the trailing twelve-month figure through Mar 2026 was $594000.0 (down 81.53% YoY), and the FY2025 annual result was $49000.0, down 98.32% from the prior year.
• Other financing activities slipped to $148000.0 in Q1 2026 per AYTU's latest filing, from $283000.0 in the prior quarter.
• Over five years, Other financing activities peaked at $5.3 million in Q2 2022 and troughed at $49000.0 in Q2 2025.
• A 5-year average of $1.1 million and a median of $815500.0 in 2023 frame the typical range for Other financing activities.
• The sharpest annual moves came in 2022 and 2025: Other financing activities soared 19516.67% in 2022, then plunged 98.22% in 2025.
• A 5-year view of Other financing activities shows it stood at $3.1 million in 2022, then tumbled by 73.26% to $820000.0 in 2023, then sank by 81.59% to $151000.0 in 2024, then soared by 87.42% to $283000.0 in 2025, then slumped by 47.7% to $148000.0 in 2026.
• Business Quant data shows AYTU's Other financing activities at $148000.0 in Q1 2026, $283000.0 in Q4 2025, and $114000.0 in Q3 2025.